Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | HTR2A | P28223 | 4/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.58 |
| ▸ | HRH1 | P35367 | 4/20 | 0.58 |
| ▸ | DRD3 | P35462 | 4/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | DRD2 | P14416 | 2/20 | 0.58 |
| ▸ | MLNR | O43193 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | PGR | P06401 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mioflazine SCHEMBL8675598 | 0.99 | SLC29A1 (0.69) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| Mioflazine SCHEMBL611300 | 0.98 | SLC29A1 (0.68) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| Mioflazine SCHEMBL119416 | 0.98 | SLC29A1 (0.68) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| SCHEMBL10681498 | 0.93 | SLC29A1 (0.60) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| SCHEMBL7700344 | 0.92 | SLC29A1 (0.61) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| Hydrochloric Acid SCHEMBL30720033 | 0.92 | SLC29A1 (0.60) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| Hydrochloric Acid SCHEMBL7705419 | 0.91 | SLC29A1 (0.59) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| Hydrochloric Acid SCHEMBL10678583 | 0.90 | SLC29A1 (0.81) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| SCHEMBL10459777 | 0.90 | SLC29A1 (0.78) | SLC29A1KMT2AHTR2AADRA1AHRH1 | |
| SCHEMBL10676648 | 0.90 | ADRA1A (0.73) | SLC29A1KMT2AHTR2AADRA1AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025074343-A2 | PRODRUGS OF HUMAN DIHYDROOROTATE DEHYDROGENASE (hDHODH) INHIBITORS | DRUG DISCOVERY AND CLINIC S.R.L. (IT) | 2025-04-10 | — | — | WO | claimed |
| US-20230414575-A1 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | AKTTYVA THERAPEUTICS INC (US) | 2023-12-28 | — | — | US | claimed |
| EP-4244341-A2 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | Akttyva Therapeutics, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| WO-2022104097-A2 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | AKTTYVA THERAPEUTICS, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| US-20220008334-A1 | GASTRIC RETENTIVE DEVICES | CLEXIO BIOSCIENCES LTD. (IL) | 2022-01-13 | — | — | US | claimed |
| US-11147766-B2 | Gastric retentive devices | CLEXIO BIOSCIENCES LTD. (IL) | 2021-10-19 | — | — | US | claimed |
| EP-2205639-B1 | ANTI-PCSK9 AND METHODS FOR TREATING LIPID AND CHOLESTEROL DISORDERS | MERCK SHARP & DOHME (US) | 2015-12-23 | — | — | EP | claimed |
| EP-1461039-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CILOSTAZOL AND AN ADENOSINE UPTAKE INHIBITOR | OTSUKA PHARMA CO LTD (JP) | 2014-10-22 | — | — | EP | claimed |
| EP-2032124-A1 | MULTIPARTICULATE OSMOTIC DELIVERY SYSTEM | BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) | 2009-03-11 | — | — | EP | claimed |
| CN-101365451-A | Methods of using small molecule compounds for neuroprotection | UNIV ALABAMA (US) | 2009-02-11 | — | — | CN | claimed |
| WO-1992000729-A1 | DOSAGE FORM FOR ADMINISTERING A DRUG TO EFFECT CIRCADIAN THERAPY | ALZA CORPORATION (US) | 1992-01-23 | — | — | WO | claimed |
| WO-1991015196-A1 | OSMOTIC DOSAGE SYSTEM FOR LIQUID DRUG DELIVERY | ALZA CORPORATION (US) | 1991-10-17 | — | — | WO | claimed |
| EP-0416011-A4 | CHEMOTHERAPEUTIC COMPOSITION FOR AIDS | US COMMERCE (US) | 1991-05-22 | — | — | EP | claimed |
| EP-0416011-A1 | CHEMOTHERAPEUTIC COMPOSITION FOR AIDS | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1991-03-13 | — | — | EP | claimed |
| WO-1989011274-A1 | CHEMOTHERAPEUTIC COMPOSITION FOR AIDS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH (US) | 1989-11-30 | — | — | WO | claimed |
| US-4783337-A | Osmotic system comprising plurality of members for dispensing drug | ALZA CORPORATION (US) | 1988-11-08 | — | — | US | claimed |
| US-4766125-A | N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia | JANSSEN PHARMACEUTICA N.V. (BE) | 1988-08-23 | — | — | US | claimed |
| EP-0068544-B1 | NOVEL N-ARYL-PIPERAZINEALKANAMIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1987-06-03 | — | — | EP | claimed |
| EP-0217580-A2 | Therapeutic nucleosides | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-04-08 | — | — | EP | claimed |
| EP-0068544-A2 | Novel N-aryl-piperazinealkanamides | JANSSEN PHARMACEUTICA N.V. (BE) | 1983-01-05 | — | — | EP | claimed |